STAND+
Techstars '21New York City, US · Founded 2020 · 4 known investors
Find your way into STAND+
Sign up to see every warm intro you have to STAND+
- Paths you didn't know you had: your email and LinkedIn already hold routes to the STAND+ team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Gales designs and manufactures antimicrobial protective footwear for healthcare professionals, featuring patented seamless technology, medical-grade insoles, and machine-washable materials. The company combines safety, comfort, and affordability for frontline workers at risk of exposure to infectious fluids.
Also known as Gales · Gales Footwear · STAND · STAND+
Founders & leadership
STAND+ was founded in 2020 by Rob Gregg.

Investors · 4
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Company profile
researched Sep 2026STAND+ (also marketed under the Gales brand) designs and sells footwear aimed at people who spend long hours standing or walking, including nurses and other healthcare professionals, hospitality and kitchen staff, athletes in recovery, and frequent travelers. The company describes its core approach as "energy-recovery" or energy-dissipation footwear: rather than compressing and returning impact energy upward into the joints as running-oriented energy-return soles do, its outsole and insole system is designed to absorb impact and disperse it laterally to reduce joint stress and fatigue over long shifts.
The product line includes three flagship shoes — AntiGrav1 ($120), a heat-moldable energy-dissipation shoe; AntiGrav2 ($140), with ASTM-certified slip-resistant soles for kitchen and wet floors; and AntiGrav3 ($65), which uses DualCush dual-density cushioning — plus the Ortholite X-40 Recovery Insole sold separately at $45. The Gales Frontline shoe ($90) is positioned for nurses and healthcare professionals and is described as antimicrobial, waterproof, bleachable, machine washable and arch-supportive, built with XL Extralight construction and Ortholite insoles. Stated product features across the line include an average weight of 5.7 ounces, a removable machine-washable insole with arch contouring and heel cup, a heat-moldable fit achieved with 15-30 seconds of hair-dryer heat, slip-resistant outsoles, and fluid-resistant antimicrobial materials.
The company states its products carry the American Podiatric Medical Association Seal of Acceptance, are HSA/FSA eligible through Truemed, and are the subject of biomechanics research conducted with Heeluxe on energy dissipation and joint stress reduction. It also says its shoes are worn by athletes across the NFL, NBA and Premier League for recovery.
Founding story
The Gales brand states it was founded to better protect the more than 59 million healthcare professionals who are exposed to infectious fluids and disease while wearing standard footwear.
Business model
Direct-to-consumer sale of footwear and accessories through the company's own e-commerce storefronts (weargales.com and standshoes.com), with products priced from $45 for recovery insoles to $65-$140 for shoes. Purchases can be made with health savings and flexible spending account funds via Truemed for qualified customers, and unworn items can be returned within 30 days.
Product sales of shoes and insoles at fixed retail prices through the company's online stores, including pre-orders on some models.
Traction
The company's site reports more than 100,000 customers, a 4.8 average product rating, over 2,600 five-star reviews, and a claim that 94% of users reported pain relief in the first week. The Gales Frontline nurse shoe page shows 867 reviews.
▸Full profile — market position, technology, go-to-market, geography
Market position
Positions itself within the recovery and occupational-comfort footwear segment, contrasting its energy-dissipation design with mainstream energy-return running and recovery shoes and citing a customer base of more than 100,000 alongside a 4.8 average rating and over 2,600 five-star reviews.
The company positions itself against conventional energy-return recovery shoes by using an energy-dissipation sole system that disperses impact laterally rather than returning it upward through the joints. It also claims to be the only recovery shoe combining APMA certification, HSA/FSA eligibility, a heat-moldable custom fit and biomechanics research in a single product, alongside features such as machine-washable antimicrobial uppers and a 5.7-ounce average weight.
Technology
An outsole and insole system engineered for energy dissipation, dispersing impact laterally instead of returning it upward. Stated components include the Ortholite X-40 removable, machine-washable recovery insole with arch contouring and heel cup; DualCush dual-density cushioning in the AntiGrav3; a heat-moldable upper that conforms to the foot after 15-30 seconds of hair-dryer heat with no break-in period; slip-resistant outsoles, with ASTM certification on the AntiGrav2; XL Extralight construction averaging 5.7 ounces; and fluid-resistant, antimicrobial, machine-washable exteriors.
Go-to-market
Online direct-to-consumer sales supported by an on-site fit quiz that matches shoppers to a product and size in four questions, which the company says reduces returns by 40%. Marketing emphasizes clinical and professional endorsements (APMA Seal of Acceptance, podiatrist recommendation, Heeluxe biomechanics studies), customer reviews, HSA/FSA payment eligibility, and adoption by professional athletes.
Standing professionals such as nurses and healthcare workers, hospitality and kitchen staff, athletes using the shoes on recovery days, and everyday movers and travelers.
Geography
Sells online with prices listed in USD.
Compiled by commissioned research from 4 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Related companies · 7
Companies working in the same space as STAND+.
▸Research sources · 4
primary sources listed
- STAND+weargales.com · web
4 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does STAND+ do?
- STAND+ (Gales) makes energy-dissipation "recovery" footwear for nurses, hospitality workers and athletes who stand for long hours.
- Who founded STAND+?
- STAND+ was founded by Rob Gregg in 2020.
- Who are STAND+'s investors?
- STAND+'s investors include Hannah Grey Ventures, Longley Capital, Techstars, Women's Equity Lab.
- Where is STAND+ headquartered?
- STAND+ is headquartered in New York City, US.





